Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts

Tobias Longin Haas, Henning Walczak, Ronald Koschny, Daniela Willen, Manuela B. Schader, Jaromir Sykora, Tom M. Ganten

Risultato della ricerca: Contributo in libroChapter

5 Citazioni (Scopus)

Abstract

The death ligand TRAIL was discovered just over 10 years ago. In this chapter, we summarize the most important findings on the biochemistry, biology and potential therapeutic applicability of this promising novel cytokine. We address a number of eminent questions. How does TRAIL apoptosis signaling work and what is special about it? Why is this member of the tumor necrosis factor family of cytokines so interesting for cancer researchers and immunologists? What is the physiological role of the TRAIL–TRAIL receptor system? We cannot provide full answers to all of these questions; however, we intend to point out to the reader the most important unsolved scientific questions regarding the biology of this fascinating cytokine and its receptors.
Lingua originaleEnglish
Titolo della pubblicazione ospiteApoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts Volume 1, 26 May 2008
Pagine31-92
Numero di pagine62
Volume1
DOI
Stato di pubblicazionePubblicato - 2008

Keywords

  • Biochemistry
  • Genetic aberrations
  • Medicine (all)
  • Physiological function
  • Signaling
  • Tumor tissue

Fingerprint Entra nei temi di ricerca di 'Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts'. Insieme formano una fingerprint unica.

Cita questo